BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11486699)

  • 1. Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: a randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine.
    Osoba D; Northfelt DW; Budd DW; Himmelberger D
    Cancer Invest; 2001; 19(6):573-80. PubMed ID: 11486699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
    J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
    Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
    Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy.
    Northfelt DW; Dezube BJ; Thommes JA; Levine R; Von Roenn JH; Dosik GM; Rios A; Krown SE; DuMond C; Mamelok RD
    J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM
    AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
    Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
    J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of liposomal anthracyclines in Kaposi's sarcoma.
    Krown SE; Northfelt DW; Osoba D; Stewart JS
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):36-52. PubMed ID: 15717737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma.
    Coukell AJ; Spencer CM
    Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
    Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
    Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome.
    Gelmann EP; Longo D; Lane HC; Fauci AS; Masur H; Wesley M; Preble OT; Jacob J; Steis R
    Am J Med; 1987 Mar; 82(3):456-62. PubMed ID: 2435150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOXIL superior for KS.
    Posit Aware; 1995; ():7. PubMed ID: 11362576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced epidemic Kaposi's sarcoma: treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine.
    Hernández DE; Pérez JR
    Int J Dermatol; 1996 Nov; 35(11):831-3. PubMed ID: 8915746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Kaposi's sarcoma: clinical findings and results of therapy.
    Gill PS; Akil B; Colletti P; Rarick M; Loureiro C; Bernstein-Singer M; Krailo M; Levine AM
    Am J Med; 1989 Jul; 87(1):57-61. PubMed ID: 2472743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.